Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Liquid Biopsy For Cancer Diagnostics
1.2 Key Market Segments
1.2.1 Liquid Biopsy For Cancer Diagnostics Segment by Type
1.2.2 Liquid Biopsy For Cancer Diagnostics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Liquid Biopsy For Cancer Diagnostics Market Overview
2.1 Global Market Overview
2.1.1 Global Liquid Biopsy For Cancer Diagnostics Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Liquid Biopsy For Cancer Diagnostics Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Liquid Biopsy For Cancer Diagnostics Market Competitive Landscape
3.1 Global Liquid Biopsy For Cancer Diagnostics Sales by Manufacturers (2019-2024)
3.2 Global Liquid Biopsy For Cancer Diagnostics Revenue Market Share by Manufacturers (2019-2024)
3.3 Liquid Biopsy For Cancer Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Liquid Biopsy For Cancer Diagnostics Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Liquid Biopsy For Cancer Diagnostics Sales Sites, Area Served, Product Type
3.6 Liquid Biopsy For Cancer Diagnostics Market Competitive Situation and Trends
3.6.1 Liquid Biopsy For Cancer Diagnostics Market Concentration Rate
3.6.2 Global 5 and 10 Largest Liquid Biopsy For Cancer Diagnostics Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Liquid Biopsy For Cancer Diagnostics Industry Chain Analysis
4.1 Liquid Biopsy For Cancer Diagnostics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Liquid Biopsy For Cancer Diagnostics Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Liquid Biopsy For Cancer Diagnostics Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Liquid Biopsy For Cancer Diagnostics Sales Market Share by Type (2019-2024)
6.3 Global Liquid Biopsy For Cancer Diagnostics Market Size Market Share by Type (2019-2024)
6.4 Global Liquid Biopsy For Cancer Diagnostics Price by Type (2019-2024)
7 Liquid Biopsy For Cancer Diagnostics Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Liquid Biopsy For Cancer Diagnostics Market Sales by Application (2019-2024)
7.3 Global Liquid Biopsy For Cancer Diagnostics Market Size (M USD) by Application (2019-2024)
7.4 Global Liquid Biopsy For Cancer Diagnostics Sales Growth Rate by Application (2019-2024)
8 Liquid Biopsy For Cancer Diagnostics Market Segmentation by Region
8.1 Global Liquid Biopsy For Cancer Diagnostics Sales by Region
8.1.1 Global Liquid Biopsy For Cancer Diagnostics Sales by Region
8.1.2 Global Liquid Biopsy For Cancer Diagnostics Sales Market Share by Region
8.2 North America
8.2.1 North America Liquid Biopsy For Cancer Diagnostics Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Liquid Biopsy For Cancer Diagnostics Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Liquid Biopsy For Cancer Diagnostics Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Liquid Biopsy For Cancer Diagnostics Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Liquid Biopsy For Cancer Diagnostics Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 F. Hoffman La Roche Ltd.
9.1.1 F. Hoffman La Roche Ltd. Liquid Biopsy For Cancer Diagnostics Basic Information
9.1.2 F. Hoffman La Roche Ltd. Liquid Biopsy For Cancer Diagnostics Product Overview
9.1.3 F. Hoffman La Roche Ltd. Liquid Biopsy For Cancer Diagnostics Product Market Performance
9.1.4 F. Hoffman La Roche Ltd. Business Overview
9.1.5 F. Hoffman La Roche Ltd. Liquid Biopsy For Cancer Diagnostics SWOT Analysis
9.1.6 F. Hoffman La Roche Ltd. Recent Developments
9.2 Thermo Fisher Scientific Inc.
9.2.1 Thermo Fisher Scientific Inc. Liquid Biopsy For Cancer Diagnostics Basic Information
9.2.2 Thermo Fisher Scientific Inc. Liquid Biopsy For Cancer Diagnostics Product Overview
9.2.3 Thermo Fisher Scientific Inc. Liquid Biopsy For Cancer Diagnostics Product Market Performance
9.2.4 Thermo Fisher Scientific Inc. Business Overview
9.2.5 Thermo Fisher Scientific Inc. Liquid Biopsy For Cancer Diagnostics SWOT Analysis
9.2.6 Thermo Fisher Scientific Inc. Recent Developments
9.3 Agilent Technologies Inc.
9.3.1 Agilent Technologies Inc. Liquid Biopsy For Cancer Diagnostics Basic Information
9.3.2 Agilent Technologies Inc. Liquid Biopsy For Cancer Diagnostics Product Overview
9.3.3 Agilent Technologies Inc. Liquid Biopsy For Cancer Diagnostics Product Market Performance
9.3.4 Agilent Technologies Inc. Liquid Biopsy For Cancer Diagnostics SWOT Analysis
9.3.5 Agilent Technologies Inc. Business Overview
9.3.6 Agilent Technologies Inc. Recent Developments
9.4 Illumina Inc.
9.4.1 Illumina Inc. Liquid Biopsy For Cancer Diagnostics Basic Information
9.4.2 Illumina Inc. Liquid Biopsy For Cancer Diagnostics Product Overview
9.4.3 Illumina Inc. Liquid Biopsy For Cancer Diagnostics Product Market Performance
9.4.4 Illumina Inc. Business Overview
9.4.5 Illumina Inc. Recent Developments
9.5 The Menarini Group
9.5.1 The Menarini Group Liquid Biopsy For Cancer Diagnostics Basic Information
9.5.2 The Menarini Group Liquid Biopsy For Cancer Diagnostics Product Overview
9.5.3 The Menarini Group Liquid Biopsy For Cancer Diagnostics Product Market Performance
9.5.4 The Menarini Group Business Overview
9.5.5 The Menarini Group Recent Developments
9.6 Bio-Rad Laboratories Inc.
9.6.1 Bio-Rad Laboratories Inc. Liquid Biopsy For Cancer Diagnostics Basic Information
9.6.2 Bio-Rad Laboratories Inc. Liquid Biopsy For Cancer Diagnostics Product Overview
9.6.3 Bio-Rad Laboratories Inc. Liquid Biopsy For Cancer Diagnostics Product Market Performance
9.6.4 Bio-Rad Laboratories Inc. Business Overview
9.6.5 Bio-Rad Laboratories Inc. Recent Developments
9.7 QIAGEN Inc.
9.7.1 QIAGEN Inc. Liquid Biopsy For Cancer Diagnostics Basic Information
9.7.2 QIAGEN Inc. Liquid Biopsy For Cancer Diagnostics Product Overview
9.7.3 QIAGEN Inc. Liquid Biopsy For Cancer Diagnostics Product Market Performance
9.7.4 QIAGEN Inc. Business Overview
9.7.5 QIAGEN Inc. Recent Developments
9.8 Exact Sciences Corporation
9.8.1 Exact Sciences Corporation Liquid Biopsy For Cancer Diagnostics Basic Information
9.8.2 Exact Sciences Corporation Liquid Biopsy For Cancer Diagnostics Product Overview
9.8.3 Exact Sciences Corporation Liquid Biopsy For Cancer Diagnostics Product Market Performance
9.8.4 Exact Sciences Corporation Business Overview
9.8.5 Exact Sciences Corporation Recent Developments
9.9 Bio-Techne Corporation
9.9.1 Bio-Techne Corporation Liquid Biopsy For Cancer Diagnostics Basic Information
9.9.2 Bio-Techne Corporation Liquid Biopsy For Cancer Diagnostics Product Overview
9.9.3 Bio-Techne Corporation Liquid Biopsy For Cancer Diagnostics Product Market Performance
9.9.4 Bio-Techne Corporation Business Overview
9.9.5 Bio-Techne Corporation Recent Developments
9.10 ArcherDX Inc.
9.10.1 ArcherDX Inc. Liquid Biopsy For Cancer Diagnostics Basic Information
9.10.2 ArcherDX Inc. Liquid Biopsy For Cancer Diagnostics Product Overview
9.10.3 ArcherDX Inc. Liquid Biopsy For Cancer Diagnostics Product Market Performance
9.10.4 ArcherDX Inc. Business Overview
9.10.5 ArcherDX Inc. Recent Developments
9.11 Neogenomics Laboratories Inc.
9.11.1 Neogenomics Laboratories Inc. Liquid Biopsy For Cancer Diagnostics Basic Information
9.11.2 Neogenomics Laboratories Inc. Liquid Biopsy For Cancer Diagnostics Product Overview
9.11.3 Neogenomics Laboratories Inc. Liquid Biopsy For Cancer Diagnostics Product Market Performance
9.11.4 Neogenomics Laboratories Inc. Business Overview
9.11.5 Neogenomics Laboratories Inc. Recent Developments
9.12 Guardant Health Inc.
9.12.1 Guardant Health Inc. Liquid Biopsy For Cancer Diagnostics Basic Information
9.12.2 Guardant Health Inc. Liquid Biopsy For Cancer Diagnostics Product Overview
9.12.3 Guardant Health Inc. Liquid Biopsy For Cancer Diagnostics Product Market Performance
9.12.4 Guardant Health Inc. Business Overview
9.12.5 Guardant Health Inc. Recent Developments
9.13 Myriad Genetics Inc.
9.13.1 Myriad Genetics Inc. Liquid Biopsy For Cancer Diagnostics Basic Information
9.13.2 Myriad Genetics Inc. Liquid Biopsy For Cancer Diagnostics Product Overview
9.13.3 Myriad Genetics Inc. Liquid Biopsy For Cancer Diagnostics Product Market Performance
9.13.4 Myriad Genetics Inc. Business Overview
9.13.5 Myriad Genetics Inc. Recent Developments
9.14 Foundation Medicine Inc.
9.14.1 Foundation Medicine Inc. Liquid Biopsy For Cancer Diagnostics Basic Information
9.14.2 Foundation Medicine Inc. Liquid Biopsy For Cancer Diagnostics Product Overview
9.14.3 Foundation Medicine Inc. Liquid Biopsy For Cancer Diagnostics Product Market Performance
9.14.4 Foundation Medicine Inc. Business Overview
9.14.5 Foundation Medicine Inc. Recent Developments
9.15 Amoy Diagnostics Co. Ltd.
9.15.1 Amoy Diagnostics Co. Ltd. Liquid Biopsy For Cancer Diagnostics Basic Information
9.15.2 Amoy Diagnostics Co. Ltd. Liquid Biopsy For Cancer Diagnostics Product Overview
9.15.3 Amoy Diagnostics Co. Ltd. Liquid Biopsy For Cancer Diagnostics Product Market Performance
9.15.4 Amoy Diagnostics Co. Ltd. Business Overview
9.15.5 Amoy Diagnostics Co. Ltd. Recent Developments
9.16 Biocartis Group NV
9.16.1 Biocartis Group NV Liquid Biopsy For Cancer Diagnostics Basic Information
9.16.2 Biocartis Group NV Liquid Biopsy For Cancer Diagnostics Product Overview
9.16.3 Biocartis Group NV Liquid Biopsy For Cancer Diagnostics Product Market Performance
9.16.4 Biocartis Group NV Business Overview
9.16.5 Biocartis Group NV Recent Developments
10 Liquid Biopsy For Cancer Diagnostics Market Forecast by Region
10.1 Global Liquid Biopsy For Cancer Diagnostics Market Size Forecast
10.2 Global Liquid Biopsy For Cancer Diagnostics Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Liquid Biopsy For Cancer Diagnostics Market Size Forecast by Country
10.2.3 Asia Pacific Liquid Biopsy For Cancer Diagnostics Market Size Forecast by Region
10.2.4 South America Liquid Biopsy For Cancer Diagnostics Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Liquid Biopsy For Cancer Diagnostics by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Liquid Biopsy For Cancer Diagnostics Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Liquid Biopsy For Cancer Diagnostics by Type (2025-2030)
11.1.2 Global Liquid Biopsy For Cancer Diagnostics Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Liquid Biopsy For Cancer Diagnostics by Type (2025-2030)
11.2 Global Liquid Biopsy For Cancer Diagnostics Market Forecast by Application (2025-2030)
11.2.1 Global Liquid Biopsy For Cancer Diagnostics Sales (K Units) Forecast by Application
11.2.2 Global Liquid Biopsy For Cancer Diagnostics Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
